Literature DB >> 9879535

Frequent expression of the c-kit proto-oncogene in canine malignant mammary tumor.

K Kubo1, S Matsuyama, K Katayama, C Tsutsumi, K Yonezawa, T Shimada, T Kotani, S Sakuma, F Ohashi, Y Takamori.   

Abstract

The mammary tumor is one of the popular neoplastic diseases in female dogs. In the present study, the expression of canine c-kit proto-oncogene in mammary tumor specimens was investigated to evaluate its potential usefulness as a tumor marker. By comparing the homology among the nucleotide sequences reported for human mouse, rat and feline c-kit c-DNA, a pair of primers was synthesized for the reverse transcriptase-polymerase chain reaction (RT-PCR) method. The RT-PCR product of canine spleen total RNA was shown to have 756 bp in size and to be highly homologous to the corresponding sequences reported for the mammalian species. The expression of c-kit transcript was detected in 11 mammary tumors of different histopathology including adenocarcinomas, benign and malignant mixed tumors. The level of the transcription in adenocarcinomas was significantly higher than those in malignant mixed tumors. Fifteen canine tumor specimens originated from various tissues were also tested for their c-kit transcript. In all of the mastocytoma samples examined, high expression of the mRNA was detected. Of other 12 tumors, only low level of RT-PCR products were detected in 5 samples, whereas no apparent amplification was observed in 7 tumors. These results indicate that the high expression of c-kit transcript is helpful for the diagnosis of canine mammary tumors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9879535     DOI: 10.1292/jvms.60.1335

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  6 in total

Review 1.  Transcriptome and proteome research in veterinary science: what is possible and what questions can be asked?

Authors:  Robert Klopfleisch; Achim D Gruber
Journal:  ScientificWorldJournal       Date:  2012-01-04

2.  Cloning and expression analysis of prohibitin mRNA in canine mammary tumors.

Authors:  Satoshi Matsuyama; Yuko Nakano; Mieko Nakamura; Ryohei Yamamoto; Terumasa Shimada; Fumihito Ohashi; Kihei Kubo
Journal:  J Vet Med Sci       Date:  2014-10-14       Impact factor: 1.267

3.  Senescence Marker Protein 30 (SMP30): A Novel Pan-Species Diagnostic Marker for the Histopathological Diagnosis of Breast Cancer in Humans and Animals.

Authors:  Su-Min Baek; Seoung-Woo Lee; Tae-Un Kim; Seong-Kyoon Choi; Sungho Yun; Won-Jae Lee; Se-Hyeon Han; Il-Hwa Hong; Sang-Joon Park; Tae-Hwan Kim; Kyu-Shik Jeong; Jin-Kyu Park
Journal:  Int J Mol Sci       Date:  2021-02-26       Impact factor: 5.923

4.  Effects of Tyrosine Kinase Inhibitor-masitinib Mesylate on Canine Mammary Tumour Cell Lines.

Authors:  Fulya Ustun-Alkan; Tülay Bakırel; Oya Üstüner; Ceren Anlas; Suzan Cinar; Funda Yıldırım; Aydın Gürel
Journal:  J Vet Res       Date:  2021-07-24       Impact factor: 1.744

5.  Intratumoral CD3+ T-lymphocytes immunoexpression and its association with c-Kit, angiogenesis, and overall survival in malignant canine mammary tumors.

Authors:  Maria Isabel Carvalho; Isabel Pires; Marlene Dias; Justina Prada; Hugo Gregório; Luis Lobo; Felisbina Queiroga
Journal:  Anal Cell Pathol (Amst)       Date:  2015-08-05       Impact factor: 2.916

Review 6.  Naturally-Occurring Canine Mammary Tumors as a Translational Model for Human Breast Cancer.

Authors:  Mark Gray; James Meehan; Carlos Martínez-Pérez; Charlene Kay; Arran K Turnbull; Linda R Morrison; Lisa Y Pang; David Argyle
Journal:  Front Oncol       Date:  2020-04-28       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.